Coherus BioSciences Inc (NAS:CHRS)
$ 1.78 0.02 (1.14%) Market Cap: 204.21 Mil Enterprise Value: 423.31 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 42/100

Q1 2022 Coherus BioSciences Inc Earnings Call Transcript

May 05, 2022 / 08:30PM GMT
Release Date Price: $8.82 (-9.26%)
Operator

Good day, and thank you for standing by. Welcome to the Coherus Biosciences Inc. First Quarter 2022 Earnings Conference Call. (Operator Instructions) After the speaker presentation, there will be a question-and-answer session. (Operator Instructions) I would now like to hand the conference over to your speaker today, McDavid Stilwell, Chief Financial Officer. Please go ahead.

McDavid Stilwell
Coherus BioSciences, Inc. - CFO

Thank you, operator. Good afternoon, everyone, and thank you for joining us. We issued a press release earlier announcing our financial results for the first quarter of 2022, and the results can be found on the release -- can be found on the Coherus BioSciences website.

Today's call includes forward-looking statements regarding Coherus' current expectations about future events. These statements include, but are not limited to, our ability to advance our product candidates through development and registration, the status of our product candidate clinical profile, our timing and ability to commercialize our products and product

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot